Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:7:421-8.
doi: 10.2147/TCRM.S16892. Epub 2011 Oct 31.

Role of iron supplementation in promoting maternal and fetal outcome

Zahra Yekta  1 , Reza Pourali, Nikol Mladkova, Mohammad Ghasemi-Rad, Farzane Boromand, Khosrow Hazrati Tappeh
Affiliations

Role of iron supplementation in promoting maternal and fetal outcome

Zahra Yekta et al. Ther Clin Risk Manag. 2011.

Abstract

Background: The data comparing daily versus intermittent iron supplementation during pregnancy remain controversial. This study was undertaken to compare the efficacy of daily versus two different intermittent iron supplementation regimes on hematologic markers and birth outcomes in nonanemic pregnant women.

Methods: Two hundred and ten women with singleton pregnancies, no known disease, and hemoglobin levels >11.0 g/dL were randomly assigned to one of three groups, ie, Group A consuming two iron supplementation tablets once weekly (100 mg iron per week, n = 70), Group B consuming one tablet twice weekly (100 mg iron per week, n = 70) and Group C, consuming one tablet daily (50 mg iron per day, n = 70). No additional micronutrients were supplied. Hemoglobin and serum ferritin levels were measured at 20, 28, and 38 weeks. Pregnancy and birth outcomes (pregnancy termination, method of delivery, birth weight, stillbirth) were analyzed.

Results: In total, 201 women completed the protocol. There was a significant difference in mean hemoglobin and ferritin levels in Group B at 38 weeks (P = 0.018 and P = 0.035, respectively) but this difference was not clinically significant (hemoglobin >12 g/dL, ferritin >19 μg/L). There was a significant increase in ferritin in Group C (P = 0.03) at 28 weeks. No significant difference was observed with respect to pregnancy or birth outcome across the groups. All regimens prevented the occurrence of hemoglobin <10.5 g/dL, but weekly supplementation was associated with development of a hemoglobin level <11.0 g/dL (risk ratio 0.044).

Conclusion: Twice-weekly supplementation is as effective as daily supplementation, and may represent an acceptable compromise in iron supplementation regimens for nonanemic pregnant women.

Keywords: anemia; iron supplementation; outcome; pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of clinical study.
Figure 2
Figure 2
Geometric means of hemoglobin level. Note: *Statistically significant.
Figure 3
Figure 3
Geometric means of ferritin level. Note: *statistically significant.
See this image and copyright information in PMC

References

    1. Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr. 2001;131(2S–2):565S–567S. - PubMed
    1. Sloan NL, Jordan E, Winikoff B. Effects of iron supplementation on maternal hematologic status in pregnancy. Am J Public Health. 2002;92(2):288–293. - PMC - PubMed
    1. Lozoff B, Georgieff MK. Iron deficiency and brain development. Semin Pediatr Neurol. 2006;13(3):158–165. - PubMed
    1. Haram K, Nilsen ST, Ulvik RJ. Iron supplementation in pregnancy – evidence and controversies. Acta Obstet Gynecol Scand. 2001;80(8):683–688. - PubMed
    1. Milman N. Iron prophylaxis in pregnancy – general or individual and in which dose? Ann Hematol. 2006;85(12):821–828. - PubMed